In vitro and in vivo studies demonstrated stable assembly, specific binding to HER3-positive tumor cells, significant accumulation within brain tumors, potent tumor growth inhibition, and low systemic toxicity. The gene discussed is ERBB3; the disease is brain neoplasm.